Screener
Indivior Pharmaceuticals, Inc. INDV Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $137M+226% | $122M+578% | $89M+89.4% | $102M+386% | $42M+90.9% | ||
| $1M-66.7% | $2M0.0% | $2M-33.3% | $2M-60.0% | $3M-25.0% | ||
| $8M+14.3% | $11M+37.5% | $9M+50.0% | $5M-16.7% | $7M+16.7% | ||
| $97M— | $229M+44.9% | -$9M-112% | -$39M— | —— | ||
| $14M-30.0% | $7M-58.8% | $20M+300% | $24M+50.0% | $20M+186% | ||
| —— | —— | —— | $0— | $0— | ||
| -$14M+30.0% | -$8M+52.9% | -$19M-280% | -$24M-400% | -$20M-157% | ||
| —— | $177M— | $125M+1,036% | —— | —— | ||
| —— | —— | $489M— | —— | —— | ||
| —— | —— | $333M+8,225% | $5M— | $4M+300% | ||
| —— | -$173M-3,360% | $7M+141% | -$5M— | -$3M+94.1% | ||
| $82M— | $48M-64.7% | -$20M-138% | -$61M-213% | —— | ||
| $83M— | $222M+57.4% | -$29M-141% | -$59M— | —— |
FAQ
- How much cash does Indivior Pharmaceuticals, Inc. generate?
- Indivior Pharmaceuticals, Inc. (INDV) generated $96.0M in operating cash flow over the trailing twelve months.
- What is Indivior Pharmaceuticals, Inc.'s free cash flow?
- After $65.0M of capital expenditures, Indivior Pharmaceuticals, Inc.'s free cash flow was $31.0M over the trailing twelve months.
- Where does Indivior Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Indivior Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
